INDEMNIFICATION AGREEMENTIndemnification Agreement • December 22nd, 2017 • Sevion Therapeutics, Inc. • Services-commercial physical & biological research • Delaware
This Indemnification Agreement (“Agreement”) is made and entered into as of December [●], 2017 by and among Eloxx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Eloxx Pharmaceuticals Ltd., an Israeli company, Eloxx Pharmaceuticals U.S. Sub, Inc., a Delaware corporation (together with the Company and Eloxx Pharmaceuticals Ltd., the “Eloxx Companies” and each an “Eloxx Company”), and [●] (“Indemnitee”).
